EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
4.1.1.53 | Migraine Disorders |
16200390 |
A genetic analysis of serotonergic biosynthetic and metabolic enzymes in migraine using a DNA pooling approach. |
diagnostic usage ongoing research unassigned |
3 4 0 |
4.1.1.53 | Parkinson Disease |
9372552 |
Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment. |
causal interaction therapeutic application unassigned |
1 4 0 |
4.1.1.53 | Parkinson Disease |
9403227 |
Effect of tolcapone on plasma levodopa concentrations after coadministration with levodopa/carbidopa to healthy volunteers. |
causal interaction therapeutic application unassigned |
3 4 0 |
4.1.1.53 | Parkinson Disease |
26366963 |
Mucuna pruriens in Parkinson Disease: A Kinetic-Dynamic Comparison With Levodopa Standard Formulations. |
therapeutic application unassigned |
2 0 |
4.1.1.53 | Parkinson Disease |
31744341 |
Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson's disease therapeutics. |
causal interaction therapeutic application unassigned |
3 4 0 |
4.1.1.53 | Parkinson Disease |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application unassigned |
1 0 |
4.1.1.53 | Ataxia |
33889127 |
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials. |
therapeutic application unassigned |
1 0 |
4.1.1.53 | Carcinogenesis |
24467211 |
Glycine decarboxylase is an unusual amino acid decarboxylase involved in tumorigenesis. |
causal interaction unassigned |
3 0 |
4.1.1.53 | Carcinoid Tumor |
13928592 |
[Amino acid decarboxylase in pheochromocytoma and carcinoid tissue.] |
causal interaction ongoing research unassigned |
1 2 0 |
4.1.1.53 | Cerebral Palsy |
1078720 |
Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. |
diagnostic usage therapeutic application unassigned |
3 1 0 |